Range Financial Group LLC purchased a new stake in Medifast, Inc. (NYSE:MED – Get Rating) in the first quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 8,052 shares of the specialty retailer’s stock, valued at approximately $1,375,000. Range Financial Group LLC owned about 0.07% of Medifast at the end of the most recent quarter.
A number of other institutional investors have also recently made changes to their positions in MED. Envestnet Asset Management Inc. lifted its holdings in shares of Medifast by 16.4% in the 4th quarter. Envestnet Asset Management Inc. now owns 5,169 shares of the specialty retailer’s stock valued at $1,082,000 after acquiring an additional 730 shares during the last quarter. Aviva PLC lifted its holdings in shares of Medifast by 70.0% in the 4th quarter. Aviva PLC now owns 12,211 shares of the specialty retailer’s stock valued at $2,557,000 after acquiring an additional 5,026 shares during the last quarter. Teacher Retirement System of Texas lifted its holdings in shares of Medifast by 19.5% in the 4th quarter. Teacher Retirement System of Texas now owns 2,150 shares of the specialty retailer’s stock valued at $450,000 after acquiring an additional 351 shares during the last quarter. Citigroup Inc. lifted its stake in Medifast by 22.9% in the fourth quarter. Citigroup Inc. now owns 11,324 shares of the specialty retailer’s stock worth $2,372,000 after purchasing an additional 2,109 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its stake in Medifast by 12.3% in the fourth quarter. JPMorgan Chase & Co. now owns 48,627 shares of the specialty retailer’s stock worth $10,183,000 after purchasing an additional 5,325 shares during the last quarter. Institutional investors own 87.66% of the company’s stock.
Wall Street Analysts Forecast Growth
Several brokerages have issued reports on MED. TheStreet downgraded shares of Medifast from a “b” rating to a “c+” rating in a research note on Tuesday, August 23rd. StockNews.com raised shares of Medifast from a “hold” rating to a “buy” rating in a research note on Thursday, September 1st. DA Davidson decreased their price objective on shares of Medifast from $352.00 to $278.00 and set a “buy” rating for the company in a research note on Thursday, August 4th. Finally, Jefferies Financial Group downgraded shares of Medifast from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $345.00 to $150.00 in a research note on Thursday, August 4th.
Insider Buying and Selling at Medifast
Medifast Stock Performance
Shares of MED stock opened at $124.56 on Wednesday. The firm has a market cap of $1.37 billion, a price-to-earnings ratio of 9.24 and a beta of 1.18. The company’s 50 day moving average is $148.70 and its 200 day moving average is $168.42. The company has a quick ratio of 0.46, a current ratio of 1.29 and a debt-to-equity ratio of 0.18. Medifast, Inc. has a 52-week low of $116.50 and a 52-week high of $235.71.
Medifast Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 8th. Investors of record on Tuesday, September 20th will be issued a dividend of $1.64 per share. This represents a $6.56 annualized dividend and a yield of 5.27%. The ex-dividend date is Monday, September 19th. Medifast’s payout ratio is 48.66%.
Medifast Company Profile
Medifast, Inc, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands.
- Get a free copy of the StockNews.com research report on Medifast (MED)
- Is Five Below Trying to Punch Too High?
- These 3 Reports Will Tell Us Much About the Current Economy
- This Is What To Expect From The S&P 500 Now
- The Two Things You Need To Know About Oracle’s FQ1 Report
- Three Value Stocks For A Volatile Market
Receive News & Ratings for Medifast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medifast and related companies with MarketBeat.com's FREE daily email newsletter.